西亚试剂优势供应上万种化学试剂产品，欢迎各位新老客户咨询、选购！
中国
联系我们

登录

￥0.00

联系方式：400-990-3999 / 邮箱：sales@xiyashiji.com

西亚试剂 —— 品质可靠，值得信赖

西亚试剂：Cardiomyocytes derived from human embryonic stem cells in p

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

Michael A Laflamme1,2,6, Kent Y Chen1,2,3,6, Anna V Naumova1,4, Veronica Muskheli1,2, James A Fugate1,2, Sarah K Dupras1,2, Hans Reinecke1,2, Chunhui Xu5, Mohammad Hassanipour5, Shailaja Police5, Chris O'Sullivan5, Lila Collins5, Yinhong Chen5, Elina Minami1,3, Edward A Gill3, Shuichi Ueno1,2, Chun Yuan1,4, Joseph Gold5 & Charles E Murry1,2

Cardiomyocytes derived from human embryonic stem (hES) cells potentially offer large numbers of cells to facilitate repair of the infarcted heart. However, this approach has been limited by inefficient differentiation of hES cells into cardiomyocytes, insufficient purity of cardiomyocyte preparations and poor survival of hES cell–derived myocytes after transplantation. Seeking to overcome these challenges, we generated highly purified human cardiomyocytes using a readily scalable system for directed differentiation that relies on activin A and BMP4. We then identified a cocktail of pro-survival factors that limits cardiomyocyte death after transplantation. These techniques enabled consistent formation of myocardial grafts in the infarcted rat heart. The engrafted human myocardium attenuated ventricular dilation and preserved regional and global contractile function after myocardial infarction compared with controls receiving noncardiac hES cell derivatives or vehicle. The ability of hES cell–derived cardiomyocytes to partially remuscularize myocardial infarcts and attenuate heart failure encourages their study under conditions that closely match human disease.

  1. Center for Cardiovascular Biology, Institute for Stem Cell and Regenerative Medicine, University of Washington, 815 Mercer Street, Seattle, Washington 98109, USA.
  2. Department of Pathology, University of Washington, 815 Mercer Street, Seattle, Washington 98109, USA.
  3. Department of Medicine/Cardiology, University of Washington, 1959 NE Pacific Street, Seattle, Washington 98195, USA.
  4. Vascular Imaging Laboratory, Department of Radiology, University of Washington, 815 Mercer Street, Seattle, Washington 98109, USA.
  5. Geron Corporation, 230 Constitution Drive, Menlo Park, California 94025, USA.
  6. These authors contributed equally to this work.